DrugPatentWatch Database Preview
Emd Serono Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for EMD SERONO, and when can generic versions of EMD SERONO drugs launch?
EMD SERONO has sixteen approved drugs.
There are nine US patents protecting EMD SERONO drugs.
There are two hundred and fifteen patent family members on EMD SERONO drugs in forty-three countries and sixty-one supplementary protection certificates in fifteen countries.
Summary for Emd Serono
| International Patents: | 215 |
| US Patents: | 9 |
| Tradenames: | 16 |
| Ingredients: | 11 |
| NDAs: | 16 |
Drugs and US Patents for Emd Serono
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emd Serono | GONAL-F | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021765-001 | Mar 25, 2004 | DISCN | No | No | Start Trial | Start Trial | |||||
| Emd Serono | GONAL-F RFF REDI-JECT | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021684-001 | May 25, 2004 | RX | Yes | Yes | 7,741,268 | Start Trial | Y | Start Trial | |||
| Emd Serono | SEROSTIM | somatropin | INJECTABLE;INJECTION | 020604-001 | Aug 23, 1996 | BX | RX | No | No | Start Trial | Start Trial | ||||
| Emd Serono | GONAL-F | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021765-003 | Mar 25, 2004 | DISCN | No | No | Start Trial | Start Trial | |||||
| Emd Serono | SAIZEN | somatropin | INJECTABLE;INJECTION | 019764-003 | Aug 29, 2000 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Emd Serono | GONAL-F RFF REDI-JECT | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021684-002 | May 25, 2004 | RX | Yes | Yes | 7,446,090 | Start Trial | Y | Start Trial | |||
| Emd Serono | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 019863-001 | Dec 28, 1990 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Emd Serono
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Emd Serono | GONAL-F RFF REDI-JECT | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021684-002 | May 25, 2004 | 5,767,067 | Start Trial |
| Emd Serono | GONAL-F RFF REDI-JECT | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021684-001 | May 25, 2004 | 5,767,067 | Start Trial |
| Emd Serono | GONAL-F | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 020378-001 | Sep 29, 1997 | 4,589,402 | Start Trial |
| Emd Serono | SAIZEN | somatropin | INJECTABLE;INJECTION | 019764-003 | Aug 29, 2000 | 5,898,030 | Start Trial |
| Emd Serono | SEROSTIM | somatropin | INJECTABLE;INJECTION | 020604-004 | Sep 6, 2001 | 5,898,030 | Start Trial |
| Emd Serono Inc | CETROTIDE | cetrorelix | INJECTABLE;INJECTION | 021197-001 | Aug 11, 2000 | 7,605,121 | Start Trial |
| Emd Serono Inc | GEREF | sermorelin acetate | INJECTABLE;INJECTION | 020443-002 | Sep 26, 1997 | 4,703,035 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Emd Serono Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1086503 | Start Trial |
| China | 101912615 | Start Trial |
| Japan | 2002512975 | Start Trial |
| Cyprus | 1112614 | Start Trial |
| Malaysia | 135913 | Start Trial |
| Ukraine | 81304 | Start Trial |
| Israel | 140984 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Emd Serono Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1506211 | C300677 | Netherlands | Start Trial | PRODUCT NAME: COMBINATIE VAN DAPAGLIFLOZINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN METFORMINE OF EEN FARMACEITISCH AANVAARDBAAR ZOUT DAARVAN, ZOALS BESCHERMD DOOR HET BASISOCTROOI EP 1506211B1; REGISTRATION NO/DATE: EU/1/13/900 20140121 |
| 0853945 | SPC/GB10/022 | United Kingdom | Start Trial | PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTERED: UK EU/1/09/609/001 20100125; UK EU/1/09/609/002 20100125 |
| 0211894 | 96C0010 | Belgium | Start Trial | PRODUCT NAME: FOLLITROPINE ALPHA; NAT. REGISTRATION NO/DATE: EU1/95/001/001 19951020; FIRST REGISTRATION: FI 11529 19940815 |
| 1506211 | CA 2014 00037 | Denmark | Start Trial | PRODUCT NAME: ET KOMBINATIONSPRODUKT AF DAPAGLIFLOZIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER DAPAGLIFLOZINPROPANDIOLMONOHYDRAT OG METFORMIN ELLER SALTE DERAF, HERUNDER METFORMINHYDROCHLORID; REG. NO/DATE: EU/1/13/900 20140116 |
| 1827461 | C201830015 | Spain | Start Trial | PRODUCT NAME: CLADRIBINA; NATIONAL AUTHORISATION NUMBER: EU/1/17/1212; DATE OF AUTHORISATION: 20170822; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1212; DATE OF FIRST AUTHORISATION IN EEA: 20170822 |
| 2805723 | PA2018503 | Lithuania | Start Trial | PRODUCT NAME: KLADRIBINAS; REGISTRATION NO/DATE: EU1/17/1212/001-006 20170822 |
| 1412357 | SPC/GB08/040 | United Kingdom | Start Trial | PRODUCT NAME: SITAGLIPTIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR THE MONOPHOSPHATE, PLUS METFORMIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR THE HYDROCHLORIDE.; REGISTERED: CH 58450 01-03 20080408; UK EU/1/08/455/001 20080716; UK EU/1/08/455/002 20080716; UK EU/1/08/455/003 20080716; UK EU/1/08/455/004 20080716; UK EU/1/08/455/005 20080716; UK EU/1/08/455/006 20080716; UK EU/1/08/455/007 20080716; UK EU/1/08/455/008 20080716; UK EU/1/08/455/009 20080716; UK EU/1/08/455/010 20080716; UK EU/1/08/455/011 20080716; UK EU/1/08/455/012 20080716; UK EU/1/08/455/013 20080716; UK EU/1/08/455/014 20080716 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
